Tai Chi Chuan as Rehabilitation Program for Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients
NCT04416841, Not applicable, Completed, Jing Tao
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Tai Chi Chuan as Rehabilitation Program for Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients | ClinicalTrials.gov |
| NCT number | NCT04416841 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 328 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Jing Tao | ClinicalTrials.gov |
| Conditions | Diabetes Mellitus, Type 2, Cognitive Dysfunction | ClinicalTrials.gov |
| Interventions | Tai Chi Chuan, Fitness Walking, Standard Diabetic Care Education | ClinicalTrials.gov |
| First posted | 2020-06-04 | ClinicalTrials.gov |
| Last updated | 2022-09-22 | ClinicalTrials.gov |
Registered outcomes 20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Global cognition-Montreal Cognitive Assessment at 36 Weeks | 36 weeks (post-intervention follow-up) | Montreal Cognitive Assessment | ClinicalTrials.gov |
| Secondary | Global cognition-Montreal Cognitive Assessment at 24 weeks | 24 weeks (post-intervention) | Montreal Cognitive Assessment | ClinicalTrials.gov |
| Secondary | Memory function-Wechsler Memory Scale at 24, 36 Weeks | 24, 36 weeks | Wechsler Memory Scale | ClinicalTrials.gov |
| Secondary | Digital Symbol test at 24, 36 weeks | 24, 36 weeks | Digital Symbol test | ClinicalTrials.gov |
| Secondary | Trial Making Test part B at 24, 36 weeks | 24, 36 weeks | Trial Making Test part B | ClinicalTrials.gov |
| Secondary | Stroop color word test at 24, 36 weeks | 24, 36 weeks | Stroop color word test | ClinicalTrials.gov |
| Secondary | Boston naming test at 24, 36 weeks | 24, 36 weeks | Boston naming test | ClinicalTrials.gov |
| Secondary | Rey-Osterrieth complex graphics test at 24, 36 weeks | 24, 36 weeks | Rey-Osterrieth complex graphics test | ClinicalTrials.gov |
| Secondary | Multi-task balance test: Time up and go test; Time up and go test + cognitive task;Time up and go test + motor task;Time up and go test + cognitive task + motor task at 24, 36 weeks | 24, 36 weeks | Time up and go test; Time up and go test + cognitive task (animal naming); Time up and go test + motor task (holding a cup of water); Time up and go test + cognitive task + motor task. | ClinicalTrials.gov |
| Secondary | Functional reach test at 24, 36 weeks | 24, 36 weeks | Functional reach test | ClinicalTrials.gov |
| Secondary | One leg stance test at 24, 36 weeks | 24, 36 weeks | One leg stance test | ClinicalTrials.gov |
| Secondary | Grip strength at 24, 36 weeks | 24, 36 weeks | Grip strength | ClinicalTrials.gov |
| Secondary | Five times sit-to-stand test at 24, 36 weeks | 24, 36 weeks | Five times sit-to-stand test | ClinicalTrials.gov |
| Secondary | Sensation function at 24, 36 weeks | 24, 36 weeks | Tactile sensation; Two-point discrimination sensation; Vibration sensation. | ClinicalTrials.gov |
| Secondary | Fall efficiency-Modified Falls Efficacy Scale at 24, 36 weeks | 24, 36 weeks | Modified Falls Efficacy Scale | ClinicalTrials.gov |
| Secondary | Quality of life-Medical Outcomes Study 36-item Short-Form Health Survey at 24, 36 weeks | 24, 36 weeks | Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) | ClinicalTrials.gov |
| Other | Blood glucose metabolism index at 24, 36 weeks | 24, 36 weeks | fasting blood glucose; glycosylated hemoglobin; fasting insulin | ClinicalTrials.gov |
| Other | Blood lipid metabolism index at 24, 36 weeks | 24, 36 weeks | total cholesterol (TC); total triglyceride (TG); low density lipoprotein (LDL),;high density lipoprotein (HDL). | ClinicalTrials.gov |
| Other | Circulating levels of AGE and sRAGE at 24, 36 weeks | 24, 36 weeks | Circulating levels of AGE and sRAGE | ClinicalTrials.gov |
| Other | functional Magnetic Resonance Imaging (fMRI) | baseline, 24 weeks | functional Magnetic Resonance Imaging | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 7
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Category Fluency | Secondary outcome | ConductCognition |
| Picture Naming Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)